| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |